Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2013-A00005-40 | Other Identifier | RCB number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of this study is to evaluate the effect of 3 months of "Snoezelen-type" multi-sensory care sessions on NeuroPsychiatric Inventory Questionnaire (NPI-Q) scores for patients with Alzheimer's-type neurodegenerative disease.
The secondary objectives of this study are to study the following elements in relationship to the implementation of a "Snoezelen-type" multi-sensory care strategy for patients with Alzheimer's-type neurodegenerative disease:
A. to evaluate the effects on NPI-Q scores at 1 month, 6 months and 12 months .
B. evaluate the effects on quality of life (questionnaire QOL-AD) at 0 and 12 months.
C. assess changes in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire over 0, 1, 3, 6 and 12 months.
D. assess changes in drug consumption (anxiolytics, antidepressants, hypnotics, neuroleptics)over the study period
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Study population | Experimental | Patients hospitalized at the Serre-Cavalier centre and who have Alzheimer's-type neurodegenerative disease (see inclusion criteria). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Multi-sensory supportive care | Other | The Serre-Cavalier center will implement Snoezelen-type multisensory care sessions for included patients; these care sessions correspond with the patients' daily hygiene/toilette care. The impact of this multisensory strategy will be evaluated using a before-after design. |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in NPI-Q scores | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in NPI-Q scores | 1 month | |
| Change from baseline in NPI-Q scores | 6 months | |
| Change from baseline in NPI-Q scores |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jane Debuysschere, IDE | Centre Hospitalier Universitaire de Nīmes | Study Director |
| Jean-Marie Cros, MD | Centre Hospitalier Universitaire de Nīmes | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Nîmes - Centre de Gérontologie de Serre Cavalier | Nîmes | 30029 | France |
Not provided
| ID | Term |
|---|---|
| D000544 | Alzheimer Disease |
| D003704 | Dementia |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D024801 | Tauopathies |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| 12 months |
| Change from baseline in the Quality-of-life-Alzheimer's Disease questionnaire (QOL-AD) | 12 months |
| Change from baseline in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire | 1 month |
| Change from baseline in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire | 3 months |
| Change from baseline in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire | 6 months |
| Change from baseline in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire | 12 months |
| Change in drug consumption from baseline | 1 month |
| Change in drug consumption from baseline | 3 months |
| Change in drug consumption from baseline | 6 months |
| Change in drug consumption from baseline | 12 months |
| D019636 |
| Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |